bupropion + anastrozole + testosterone + danazol + chlorthalidone

This entry refers to a specific group of pharmacological agents—**bupropion**, **anastrozole**, **testosterone**, **danazol**, and **chlorthalidone**—that were collectively studied by **Parc de Salut Mar** in the ESPAMA clinical trial. The study was designed to characterize the urinary excretion patterns of these substances, which are either prohibited or monitored by the World Anti-Doping Agency (WADA), to improve analytical strategies for doping control in sports. Each drug in this set serves a distinct therapeutic purpose: bupropion is a norepinephrine-dopamine reuptake inhibitor used for depression; anastrozole is an aromatase inhibitor used for breast cancer; testosterone is an androgen used for hypogonadism; danazol is an antigonadotropin used for endometriosis; and chlorthalidone is a thiazide-like diuretic used for hypertension.

Brand names

WellbutrinArimidexDepo-TestosteroneDanocrineThalitoneHygroton

Other names

WADA Prohibited Substances Excretion Studychlorthalidone-Parc de Salut Mar-depression-breast cancer-hypogonadism-endometriosis-hypertension